Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(NY:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Press releases about
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Schering-Plough Shareholders Approve Merger With Merck
August 07, 2009
from
PR Newswire
Merck Shareholders Approve Merger With Schering-Plough
August 07, 2009
from
Business Wire News Releases
Merck Shareholders Approve Merger With Schering-Plough
August 07, 2009
from
Business Wire News Releases
Schering-Plough to Webcast Special Meeting of Shareholders
August 06, 2009
from
PR Newswire
Seeger Weiss Announces Global Resolution of Zetia and Vytorin Prescription Purchase Claims -- MRK, SGP
August 05, 2009
Seeger Weiss Founding Partner, Christopher A. Seeger, Served as Chief Negotiator in the Nationwide Settlement
Read More
from
GlobeNewswire News Releases
Hagens Berman Sobol Shapiro: Vytorin and Zetia Makers Settle Class-Action Suit With Proposed $41.5 Million
August 05, 2009
from
PR Newswire
Merck and Schering-Plough Resolve Previously Disclosed Civil Class Action Lawsuits Related to VYTORIN® (ezetimibe/simvastatin) and ZETIA® (ezetimibe)
August 05, 2009
from
Business Wire News Releases
Ligand and Organon Mutually Terminate Collaboration and License Agreement
July 30, 2009
from
Business Wire News Releases
/C O R R E C T I O N -- Schering-Plough Corporation/
July 30, 2009
from
PR Newswire
FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia
July 30, 2009
from
PR Newswire
Sanofi-aventis to Acquire Merck's Interest in Merial
July 30, 2009
from
Business Wire News Releases
SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia
July 24, 2009
from
PR Newswire
Schering-Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck
July 24, 2009
from
PR Newswire
Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
July 22, 2009
from
PR Newswire
Breaking Investors Alert for Wednesday: ARWD! July 22, 2009
July 22, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.
Read More
from
Marketwired News Releases
Critical Alerts for Qualcomm, Schering-Plough, PNC, Whirlpool, and GameStop Released by Seven Summits Research
July 22, 2009
from
PR Newswire
Schering-Plough Reports Financial Results for 2009 Second Quarter
July 21, 2009
from
PR Newswire
Beacon Equity Issues Trading Outlook for Peregrine Pharmaceuticals Inc.
July 16, 2009
from
GlobeNewswire News Releases
Merck and Schering-Plough Resolve Previously Disclosed Investigation Under State Consumer Protection Statutes Related to VYTORIN® (ezetimibe/simvastatin) and ZETIA® (ezetimibe)
July 15, 2009
from
Business Wire News Releases
Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV
July 15, 2009
from
PR Newswire
AnalystChoice.com Brings You the Best Complimentary Research Report on CTX, MAR, SGP, KMP, ACH and BDN
July 14, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC).
Read More
from
Marketwired News Releases
REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients
July 09, 2009
from
PR Newswire
ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients
July 09, 2009
from
PR Newswire
Penny Stock Chaser Announces Investment Opinion on AXL, SOL, YRCW, RIGL and HEB
July 09, 2009
from
Business Wire News Releases
Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
July 01, 2009
from
PR Newswire
Schering-Plough Schedules Conference Call Webcast for 2009 Second Quarter Earnings
June 29, 2009
from
PR Newswire
TheFortuneFinancial.com Free Market Research on MOT, CVX, PNW, UPS, SGP and PEP
June 29, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by TheFortuneFinancial.com.
Read More
from
Marketwired News Releases
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
June 26, 2009
from
PR Newswire
Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
June 23, 2009
from
PR Newswire
SAFE-BioPharma Changes Fees to Help Clinical Investigators, CROs, Others
June 22, 2009
from
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here